MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ling, Y.-H.
Right arrow Articles by Perez-Soler, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ling, Y.-H.
Right arrow Articles by Perez-Soler, R.

Vol. 59, Issue 3, 593-603, March 2001

Disruption of Cell Adhesion and Caspase-Mediated Proteolysis of beta - and gamma -Catenins and APC Protein in Paclitaxel-Induced Apoptosis

Yi-He Ling, Yun Zhong, and Roman Perez-Soler

Kaplan Comprehensive Cancer Center, New York University School of Medicine, New York, New York

Cell adhesion is important in the regulation of cell proliferation, migration, survival, and apoptosis. The major components of cell adhesion are the cadherin family of proteins, alpha -, beta - and gamma -catenins, and cytoskeletons. In addition, beta -catenin, when associated with adenomatous polyposis coli (APC) protein, an oncosuppressor, is implicated in the regulation of beta -catenin/APC-related signaling pathways. To examine the correlation between impairment of cell adhesion events and apoptosis, we used human non-small-cell lung cancer H460 and H520 cell lines as models to determine whether paclitaxel-induced apoptosis is associated with disruption of the components of cell adhesion and their functions. Paclitaxel treatment resulted in cells rounding up and losing contact with their neighboring cells, suggesting that the drug does indeed affect cell adhesion and related events. Western blot analysis revealed that paclitaxel caused a time- and concentration-dependent cleavage of beta -catenin, gamma -catenin, and APC protein, but not alpha -catenin or E-cadherin. These cleavages of beta -catenin and gamma -catenin were apoptosis-dependent, not mitosis-dependent. Paclitaxel treatment led to the proteolysis and activation of caspase-3 and -7, but not caspase-1. Furthermore, paclitaxel-induced apoptosis and cleavage of beta -catenin and gamma -catenin were inhibited by the pan-caspase inhibitor Z-VAD-FMK and partially inhibited by the caspase-3 inhibitor Z-DEVD-FMK but were not affected by the caspase-1 inhibitor AC-YVAD-CMK. Although the pan-caspase inhibitor blocked the cleavage of beta -catenin as well as DNA fragmentation, it did not affect paclitaxel-induced M-phase arrest and only partially prevented cell-growth inhibition. Biochemical studies revealed that cleaved beta -catenin was detected only in the Triton X-100 insoluble fraction, suggesting that it might localize in nuclear and/or membrane structures. Interestingly, the paclitaxel-induced beta -catenin fragment lost its ability to bind to E-cadherin, alpha -catenin, or APC protein and to serve as a substrate for tyrosine kinase. All our data demonstrate that the caspase-mediated cleavage of beta -catenin, gamma -catenin, and APC protein might contribute to paclitaxel-induced apoptosis.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H.-Y. Lee, H.-J. You, J.-Y. Won, S.-W. Youn, H.-J. Cho, K.-W. Park, W.-Y. Park, J.-S. Seo, Y.-B. Park, K. Walsh, et al.
Forkhead Factor, FOXO3a, Induces Apoptosis of Endothelial Cells Through Activation of Matrix Metalloproteinases
Arterioscler. Thromb. Vasc. Biol., February 1, 2008; 28(2): 302 - 308.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. W. Childs, B. Tharakan, F. A. Hunter, J. H. Tinsley, and X. Cao
Apoptotic signaling induces hyperpermeability following hemorrhagic shock
Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3179 - H3189.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Wen, T. C. Caffrey, M. J. Wheelock, K. R. Johnson, and M. A. Hollingsworth
Nuclear Association of the Cytoplasmic Tail of MUC1 and {beta}-Catenin
J. Biol. Chem., September 26, 2003; 278(39): 38029 - 38039.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
L. Li, J. Backer, A. S. K. Wong, E. L. Schwanke, B. G. Stewart, and M. Pasdar
Bcl-2 expression decreases cadherin-mediated cell-cell adhesion
J. Cell Sci., September 15, 2003; 116(18): 3687 - 3700.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
P. L. Rice, J. Kelloff, H. Sullivan, L. J. Driggers, K. S. Beard, S. Kuwada, G. Piazza, and D. J. Ahnen
Sulindac metabolites induce caspase- and proteasome-dependent degradation of {beta}-catenin protein in human colon cancer cells
Mol. Cancer Ther., September 1, 2003; 2(9): 885 - 892.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
L. E. Broker, C. Huisman, C. G. Ferreira, J. A. Rodriguez, F. A. E. Kruyt, and G. Giaccone
Late Activation of Apoptotic Pathways Plays a Negligible Role in Mediating the Cytotoxic Effects of Discodermolide and Epothilone B in Non-Small Cell Lung Cancer Cells
Cancer Res., July 15, 2002; 62(14): 4081 - 4088.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
C. Huisman, C. G. Ferreira, L. E. Broker, J. A. Rodriguez, E. F. Smit, P. E. Postmus, F. A. E. Kruyt, and G. Giaccone
Paclitaxel Triggers Cell Death Primarily via Caspase-independent Routes in the Non-Small Cell Lung Cancer Cell Line NCI-H460
Clin. Cancer Res., February 1, 2002; 8(2): 596 - 606.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics